GRBK vs ECG
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Aug 21, 2026
GRBK
60.2
AI Score
VS
GRBK Wins
ECG
44.3
AI Score
Investment Advisor Scores
ECG
44score
Recommendation
HOLD
AI Analyst Insights
AI insights temporarily unavailable
Detailed Metrics Comparison
| Metric | GRBK | ECG | Winner |
|---|---|---|---|
| Revenue | 959.50M | 2.27B | ECG |
| Net Income | 135.12M | 142.21M | ECG |
| Gross Margin | 28.9% | 13.8% | GRBK |
| Net Margin | 14.1% | 6.3% | GRBK |
| ROE | 6.8% | 18.4% | ECG |
| ROA | 5.2% | 6.9% | ECG |
| Total Assets | 2.61B | 2.06B | GRBK |
Relative Price Performance (Last 90 Days)
GRBK 1M: +1.4%
· 3M: +8.1%
ECG 1M: -8.7%
· 3M: -16.4%
Current Technical Phase
GRBK
NeutralHold
Mixed signals - no dominant trend phase, RSI 51
ECG
MarkdownSell / avoid
Price below a falling SMA50 (slope -5.2%), weak momentum, RSI 42
Fundamentals Snapshot
| Metric | GRBK | ECG |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 11.1 | 21.0 |
| Trailing P/E | 10.7 | 26.1 |
| Revenue (TTM) | — | — |
| Revenue Growth | -0.1% | 0.3% |
| Gross Margin | 0.3% | 0.1% |
| Operating Margin | 0.2% | 0.1% |
| EPS | 6.60 | 4.81 |
| Dividend Yield | — | — |
Frequently Asked Questions
Based on our detailed analysis, GRBK is currently the stronger investment candidate, winning 3 of the key financial metrics based on our comprehensive scoring model.
We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.
Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.